Drug and Medication Analysis & Statistics, January 2013 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

871-910 of about 4 000 reports

Purchase Reports From Reputable Market Research Publishers

Androgen Antagonists -Pipeline Insights, 2014

Androgen Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Androgen Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2014

Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Angiotensin Converting Enzyme (ACE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Cannabinoid Agonists -Pipeline Insights, 2014

Cannabinoid Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 1 (CB1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 1 (CB1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug and Medication
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2014

Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cannabinoid Receptor Type 2 (CB2) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Benzodiazepine Receptor Agonist -Pipeline Insights, 2014

Benzodiazepine Receptor Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Benzodiazepine Receptor Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Beta Selective Thyroid Hormone Receptor Agonists -Pipeline Insights, 2014

Beta Selective Thyroid Hormone Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta Selective Thyroid Hormone Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
Dopamine Beta-Hydroxylase Inhibitors -Pipeline Insights, 2014

Dopamine Beta-Hydroxylase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Dopamine Beta-Hydroxylase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2014

Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Estrogen Receptor Beta Partial Agonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Glucocorticoid Receptor (GR) Antagonists -Pipeline Insights, 2014

Glucocorticoid Receptor (GR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucocorticoid Receptor (GR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists -Pipeline Insights, 2014

Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists -Pipeline Insights, 2014

Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Drug and Medication
Growth Hormone Antagonists -Pipeline Insights, 2014

Growth Hormone Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Growth Hormone Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Hormone Agonists -Pipeline Insights, 2014

Hormone Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hormone Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug and Medication
Hormone Antagonists -Pipeline Insights, 2014

Hormone Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hormone Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Interferon Receptor Binders -Pipeline Insights, 2014

Interferon Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Lipase Inhibitors -Pipeline Insights, 2014

Lipase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lipase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
L-Type Calcium Channel Blockers -Pipeline Insights, 2014

L-Type Calcium Channel Blockers -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“L-Type Calcium Channel Blockers-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2014

Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug and Medication
Melatonin Receptor Agonists -Pipeline Insights, 2014

Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2014

Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mineralocorticoid Receptor (MR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug and Medication
Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

Monoamine Oxidase Inhibitors (MAOIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Monoamine Oxidase Inhibitors (MAOIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-1 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-1 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“MT-2 Melatonin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Nicotinic Agonists -Pipeline Insights, 2014

Nicotinic Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Nicotinic Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug and Medication
Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

Norepinephrine-Dopamine Reuptake Inhibitors (NDRI) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Norepinephrine-Dopamine Reuptake Inhibitors (NDRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug and Medication
About 15 000 reports

Download Unlimited Documents from Trusted Public Sources

E-cigarette Market Forecast in the UK

  • Advertising of E-cigarettes
  • October 2014
    9 pages
  • E-cigarette  

    Smoking Treatme...  

  • United Kingdom  

    Europe  

View report >

Medication Market

October 2014

64 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Icon Group

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.